Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Visterra is a clinical-stage biotechnology company focused on developing innovative antibody-based therapies for kidney diseases and other hard-to-treat conditions. Using our proprietary technology platform, we design precision antibodies that specifically target and modulate key disease drivers. Our lead program is in Phase 2, and we’re building a robust pipeline addressing unmet medical needs. Visterra also partners with i...
Visterra is a clinical-stage biotechnology company focused on developing innovative antibody-based therapies for kidney diseases and other hard-to-treat conditions. Using our proprietary technology platform, we design precision antibodies that specifically target and modulate key disease drivers. Our lead program is in Phase 2, and we’re building a robust pipeline addressing unmet medical needs. Visterra also partners with industry leaders to advance novel antibody therapies for diseases with limited treatment options.

List your booth number for exhibitions, ask us